We are live on ! Find out more
IDIX

IDENIX PHARMACEUTICALS INC
IDIX

Delisted

IDIX was delisted on the 5th of August, 2014.

Back to rankings

0 hedge funds and large institutions have $0 invested in IDENIX PHARMACEUTICALS INC in 2014 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 130 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 131 → 0 (-131)

100% less funds holding in top 10

Funds holding in top 10: 6 → 0 (-6)

100% less capital invested

Capital invested by funds: $2.78B → $0 (-$2.78B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 130

Holders
–
Holders Change
-131
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
130
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
-$1.27B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$173M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$123M
4
BFA
BlackRock Fund Advisors
California
-$106M
5
BIT
BlackRock Institutional Trust
California
-$88.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
– -$14.5M -602,888 Closed
GF
27
Gabelli Funds
New York
– -$14.5M -600,474 Closed
GCIA
28
Gabelli & Co Investment Advisers
New York
– -$14.1M -584,480 Closed
CC
29
Carlson Capital
Texas
– -$13.9M -575,000 Closed
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
– -$13.7M -569,817 Closed
Bank of New York Mellon
31
Bank of New York Mellon
New York
– -$13.2M -548,058 Closed
TAL
32
TIG Advisors LLC
New York
– -$13.1M -544,028 Closed
SG Americas Securities
33
SG Americas Securities
New York
– -$12.8M -529,579 Closed
COPPSERS
34
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$12.3M -510,204 Closed
LIM
35
Longfellow Investment Management
Massachusetts
– -$12.1M -500,000 Closed
BM
36
Bridger Management
New York
– -$11.4M -474,800 Closed
TCIM
37
TIAA CREF Investment Management
New York
– -$10.7M -445,926 Closed
OAC
38
OMERS Administration Corp
Ontario, Canada
– -$8.96M -371,800 Closed
PCM
39
Pentwater Capital Management
Florida
– -$8.92M -370,000 Closed
Allianz Asset Management
40
Allianz Asset Management
Germany
– -$8.2M -340,000 Closed
BIM
41
BlackRock Investment Management
Delaware
– -$7.92M -328,762 Closed
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
– -$7.33M -304,096 Closed
Charles Schwab
43
Charles Schwab
California
– -$7.27M -301,591 Closed
Alyeska Investment Group
44
Alyeska Investment Group
Illinois
– -$7.23M -300,000 Closed
GC
45
Guggenheim Capital
Illinois
– -$7.08M -293,962 Closed
HA
46
Havens Advisors
New York
– -$6.05M -251,000 Closed
CC
47
CQS Cayman
Cayman Islands
– -$6.03M -250,001 Closed
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
– -$5.17M -214,577 Closed
AllianceBernstein
49
AllianceBernstein
Tennessee
– -$5.1M -211,520 Closed
WAM
50
Wolverine Asset Management
Illinois
– -$4.63M -192,054 Closed
1
2
3 4 5

IDIX Hedge Fund Activity: Q3 2014 in Review

0 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in IDENIX PHARMACEUTICALS INC (IDIX) for Q3 2014, worth a combined $0 — down 100% from $2.78B a quarter earlier.

Sellers outnumbered buyers: 130 funds closed out of IDIX and 0 opened new positions — a net loss of 130 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Baupost Group, exiting entirely with an estimated $1.27B sold.

  • 0 institutional investors held IDENIX PHARMACEUTICALS INC (IDIX) as of Q3 2014, down from 131 in Q2 2014.
  • Funds reported $0 of IDENIX PHARMACEUTICALS INC stock for Q3 2014, down 100% quarter-over-quarter.
  • 0 funds opened new IDENIX PHARMACEUTICALS INC positions in Q3 2014 and 130 closed out, a net change of -130 holders.
  • The largest IDENIX PHARMACEUTICALS INC seller in Q3 2014 was Baupost Group, an estimated $1.27B sold.

Based on aggregated 13F filings for Q3 2014.